Skip to content
2000
Volume 23, Issue 9
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Remimazolam, a novel short-acting benzodiazepine, has garnered interest in the realm of procedural sedation. Targeting a desired level of sedation requires a medication with both anesthetic and analgesic properties, particularly in non-operating room anesthetizing locations. gamma-aminobutyric acid type A receptor agonism, Remimazolam has demonstrated organ-independent metabolism and rapid time to both onset and recovery and has efficacy for procedural sedation in clinical trials. This article provides a review of the current literature on the utility of remimazolam for procedural sedation.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X367968250117034551
2025-02-06
2025-11-06

  • From This Site

    /content/journals/cn/10.2174/011570159X367968250117034551
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GreenS.M. IrwinM.G. MasonK.P. Procedural sedation: Providing the missing definition.Anaesthesia202176559860110.1111/anae.1521332701166
     [Google Scholar]
  2. Practice Guidelines for Moderate Procedural Sedation and Analgesia 2018A Report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional RadiologyAnesthesiology2018128343747910.1097/ALN.000000000000204329334501
     [Google Scholar]
  3. AndradeC.M. PatelB. GillJ. AmodeoD. KulkarniP. GoldsmithS. BachmanB. GeerkenR. KleinM. AndersonW. MiladinovicB. FernandezI. KumarA. RichterJ. VidyarthiG. Safety of gastrointestinal endoscopy with conscious sedation in patients with and without obstructive sleep apnea.J. Clin. Gastroenterol.201650319820110.1097/MCG.000000000000030525768974
     [Google Scholar]
  4. BalB.S. CrowellM.D. KohliD.R. MenendezJ. RashtiF. KumarA.S. OldenK.W. What factors are associated with the difficult-to-sedate endoscopy patient?Dig. Dis. Sci.201257102527253410.1007/s10620‑012‑2188‑222565338
     [Google Scholar]
  5. ShimizuH. HommaY. NoriiT. Incidence of adverse events among elderly vs non-elderly patients during procedural sedation and analgesia with propofol.Am. J. Emerg. Med.20214441141410.1016/j.ajem.2020.04.09432409101
     [Google Scholar]
  6. DoyleR. LinderJ. MaceS. 144 Overweight and obesity is associated with significantly increased risk of receiving an intervention in emergency department procedural sedations.Ann. Emerg. Med.2023824S62S6310.1016/j.annemergmed.2023.08.165
     [Google Scholar]
  7. AndolfattoG. LabanA.R.B. ZedP.J. StaniforthS.M. StackhouseS. MoadebiS. WillmanE. Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia: A randomized double-blind trial.Ann. Emerg. Med.2012596504512.e2, 210.1016/j.annemergmed.2012.01.01722401952
     [Google Scholar]
  8. BellolioM.F. GilaniW.I. BarrionuevoP. MuradM.H. ErwinP.J. AndersonJ.R. MinerJ.R. HessE.P. Incidence of adverse events in adults undergoing procedural sedation in the emergency department: A systematic review and meta‐analysis.Acad. Emerg. Med.201623211913410.1111/acem.1287526801209
     [Google Scholar]
  9. GaitanB.D. TrentmanT.L. FassettS.L. MuellerJ.T. AltemoseG.T. Sedation and analgesia in the cardiac electrophysiology laboratory: A national survey of electrophysiologists investigating the who, how, and why?J. Cardiothorac. Vasc. Anesth.201125464765910.1053/j.jvca.2010.11.00621251850
     [Google Scholar]
  10. MalviyaS. LewisV.T. EldevikO.P. RockwellD.T. WongJ.H. TaitA.R. Sedation and general anaesthesia in children undergoing MRI and CT: Adverse events and outcomes.Br. J. Anaesth.200084674374810.1093/oxfordjournals.bja.a01358610895749
     [Google Scholar]
  11. CotéC.J. Discharge criteria for children sedated by nonanesthesiologists: Is “safe” really safe enough?Anesthesiology2004100220720810.1097/00000542‑200402000‑0000214739788
     [Google Scholar]
  12. YounA.M. KoY.K. KimY.H. Anesthesia and sedation outside of the operating room.Korean J. Anesthesiol.201568432333110.4097/kjae.2015.68.4.32326257843
     [Google Scholar]
  13. LeroyP.L.J.M. SchipperD.M. KnapeH.J.T.A. Professional skills and competence for safe and effective procedural sedation in children: Recommendations based on a systematic review of the literature.Int. J. Pediatr.2010201011610.1155/2010/93429820652062
     [Google Scholar]
  14. PolanerD.M. HouckC.S. RockoffM.A. MancusoT.J. FinleyG.A. MaxwellL.G. CraveroJ. KainZ.N. BellC. BosenbergA. ZwassM. ValleyR. AgarwalR. SavareseA. RiceL.J. CotéC.J. DavidsonP.J. FerrariL.R. DavisP.J. Sedation, risk, and safety: Do we really have data at last?Pediatrics200110841006100810.1542/peds.108.4.100611581458
     [Google Scholar]
  15. WongT. TsaiM.H. UrmanR.D. The expansion of non-operating room anesthesia services.Perioper. Care Oper. Room Manag.20179394210.1016/j.pcorm.2017.11.008
     [Google Scholar]
  16. WongT. GeorgiadisP.L. UrmanR.D. TsaiM.H. Non-operating room anesthesia: Patient selection and special considerations.Local Reg. Anesth.2020131910.2147/LRA.S18145832021414
     [Google Scholar]
  17. RoutmanJ.S. TranB.K. ViningB.R. Non-operating room anesthesia workflow (NORA) implementation to improve start times in interventional radiology.Curr. Probl. Diag. Radiol.2024534477480
     [Google Scholar]
  18. SaundersR. DavisJ.A. KrankeP. WeissbrodR. WhitakerD.K. LightdaleJ.R. Clinical and economic burden of procedural sedation-related adverse events and their outcomes: Analysis from five countries.Ther. Clin. Risk Manag.20181439340110.2147/TCRM.S15472029535525
     [Google Scholar]
  19. HuQ. LiuX. WenC. LiD. LeiX. Remimazolam: An updated review of a new sedative and anaesthetic.Drug Des. Devel. Ther.2022163957397410.2147/DDDT.S38415536411859
     [Google Scholar]
  20. European Medicines AgencyByfavo.Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/byfavo
  21. KimK.M. Remimazolam: Pharmacological characteristics and clinical applications in anesthesiology.Anesth. Pain Med.202217111110.17085/apm.2111535139608
     [Google Scholar]
  22. RogersW.K. McDowellT.S. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.IDrugs2010131292993721154153
     [Google Scholar]
  23. NoorN. LegendreR. CloutetA. ChitneniA. VarrassiG. KayeA.D. A comprehensive review of remimazolam for sedation.Health Psychol. Res.2021912451410.52965/001c.2451434746482
     [Google Scholar]
  24. OkaS. SatomiH. SekinoR. TaguchiK. KajiwaraM. OiY. KobayashiR. Sedation outcomes for remimazolam, a new benzodiazepine.J. Oral Sci.202163320921110.2334/josnusd.21‑005134092775
     [Google Scholar]
  25. KilpatrickG.J. McIntyreM.S. CoxR.F. StaffordJ.A. PacofskyG.J. LovellG.G. WiardR.P. FeldmanP.L. CollinsH. WaszczakB.L. TilbrookG.S. CNS 7056: A novel ultra-short-acting Benzodiazepine.Anesthesiology20071071606610.1097/01.anes.0000267503.85085.c017585216
     [Google Scholar]
  26. ErnstM. BrauchartD. BoreschS. SieghartW. Comparative modeling of GABAA receptors: Limits, insights, future developments.Neuroscience2003119493394310.1016/S0306‑4522(03)00288‑412831854
     [Google Scholar]
  27. SigelE. ErnstM. The benzodiazepine binding sites of GABAA receptors.Trends Pharmacol. Sci.201839765967110.1016/j.tips.2018.03.00629716746
     [Google Scholar]
  28. KimJ.J. HibbsR.E. Direct structural insights into GABAA receptor pharmacology.Trends Biochem. Sci.202146650251710.1016/j.tibs.2021.01.01133674151
     [Google Scholar]
  29. SimonJ. WakimotoH. FujitaN. LalandeM. BarnardE.A. Analysis of the set of GABA(A) receptor genes in the human genome.J. Biol. Chem.200427940414224143510.1074/jbc.M40135420015258161
     [Google Scholar]
  30. GoetzT. ArslanA. WisdenW. WulffP. GABAA receptors: Structure and function in the basal ganglia.Prog. Brain Res.2007160214110.1016/S0079‑6123(06)60003‑417499107
     [Google Scholar]
  31. BaumannS.W. BaurR. SigelE. Individual properties of the two functional agonist sites in GABA(A) receptors.J. Neurosci.20032335111581116610.1523/JNEUROSCI.23‑35‑11158.200314657175
     [Google Scholar]
  32. McKernanR.M. RosahlT.W. ReynoldsD.S. SurC. WaffordK.A. AtackJ.R. FarrarS. MyersJ. CookG. FerrisP. GarrettL. BristowL. MarshallG. MacaulayA. BrownN. HowellO. MooreK.W. CarlingR.W. StreetL.J. CastroJ.L. RaganC.I. DawsonG.R. WhitingP.J. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype.Nat. Neurosci.20003658759210.1038/7576110816315
     [Google Scholar]
  33. ThomasP. MortensenM. HosieA.M. SmartT.G. Dynamic mobility of functional GABAA receptors at inhibitory synapses.Nat. Neurosci.20058788989710.1038/nn148315951809
     [Google Scholar]
  34. SmithK.R. DavenportE.C. WeiJ. LiX. PathaniaM. VaccaroV. YanZ. KittlerJ.T. GIT1 and βPIX are essential for GABA(A) receptor synaptic stability and inhibitory neurotransmission.Cell Rep.20149129831010.1016/j.celrep.2014.08.06125284783
     [Google Scholar]
  35. FreundT.F. Interneuron diversity series: Rhythm and mood in perisomatic inhibition.Trends Neurosci.200326948949510.1016/S0166‑2236(03)00227‑312948660
     [Google Scholar]
  36. FujiyamaF. FritschyJ.M. StephensonF.A. BolamJ.P. Synaptic localization of GABAA receptor subunits in the striatum of the rat.J. Comp. Neurol.2000416215817210.1002/(SICI)1096‑9861(20000110)416:2<158::AID‑CNE3>3.0.CO;2‑L10581463
     [Google Scholar]
  37. SaariT.I. OukariU.M. AhonenJ. OlkkolaK.T. Enhancement of GABAergic activity: Neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology.Pharmacol. Rev.201163124326710.1124/pr.110.00271721245208
     [Google Scholar]
  38. HoshinoR. OhashiN. UtaD. Actions of remimazolam on inhibitory transmission of rat spinal dorsal horn neurons.J. Pharm. Sci.20241552637310.1016/j.jphs.2024.04.002
     [Google Scholar]
  39. XieH. LuF. LiuW. WangE. WangL. ZhongM. Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy.J. Pharm. Pharmacol.202173121643165110.1093/jpp/rgab08034061162
     [Google Scholar]
  40. ZhangX. LiS. LiuJ. Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: Single-centre randomized controlled trial.BMC Anesthesiol.202121115610.1186/s12871‑021‑01373‑y34016045
     [Google Scholar]
  41. GoudraB. SinghP. Remimazolam: The future of its sedative potential.Saudi J. Anaesth.20148338839110.4103/1658‑354X.13662725191193
     [Google Scholar]
  42. KilpatrickG.J. Remimazolam: Non-clinical and clinical profile of a new sedative/anesthetic agent.Front. Pharmacol.20211269087510.3389/fphar.2021.69087534354587
     [Google Scholar]
  43. WiltshireH.R. KilpatrickG.J. TilbrookG.S. BorkettK.M. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.Anesth. Analg.2012115228429610.1213/ANE.0b013e318241f68a22253270
     [Google Scholar]
  44. LugoW.V. CamachoG.C. DagninoG.R. Remimazolam: A new ultra short acting benzodiazepine.J. Anesth. Crit. Care2016460016610.15406/jaccoa.2015.04.00166
     [Google Scholar]
  45. KondoM. YoshidaN. YoshidaM. TanakaC. TagamiT. HorikawaK. SugayaK. TakaseH. Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.Am. J. Health Syst. Pharm.2023801e53e5810.1093/ajhp/zxac26236094564
     [Google Scholar]
  46. AntonikL.J. GoldwaterD.R. KilpatrickG.J. TilbrookG.S. BorkettK.M. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.Anesth. Analg.2012115227428310.1213/ANE.0b013e31823f0c2822190555
     [Google Scholar]
  47. SchüttlerJ. EisenriedA. LerchM. FechnerJ. JeleazcovC. IhmsenH. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers.Anesthesiology2020132463665110.1097/ALN.000000000000310331972655
     [Google Scholar]
  48. ChenS. WangJ. XuX. HuangY. XueS. WuA. JinX. WangQ. LyuJ. WangS. LiY. YuY. AiD. LuoA. MinS. LiL. ZouX. LiuJ. LvP. ChaiX. SunX. ZhaoZ. ZhangJ. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: A multicentered, randomized, positive-controlled, phase III clinical trial.Am. J. Transl. Res.20201284594460332913533
     [Google Scholar]
  49. BirgenheierN.M. StuartA.R. EganT.D. Soft drugs in anesthesia: Remifentanil as prototype to modern anesthetic drug development.Curr. Opin. Anaesthesiol.202033449950510.1097/ACO.000000000000087932530892
     [Google Scholar]
  50. StöhrT. ColinP.J. OssigJ. PesicM. BorkettK. WinkleP. StruysM.M.R.F. SchippersF. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment.Br. J. Anaesth.2021127341542310.1016/j.bja.2021.05.02734246461
     [Google Scholar]
  51. KramerK.J. Remimazolam: The next evolutionary step for sedative-hypnotics.Anesth. Prog.20226911210.2344/anpr‑69‑01‑0735377927
     [Google Scholar]
  52. FreyerN. KnöspelF. DammG. GreuelS. SchneiderC. SeehoferD. StöhrT. PetersenK.U. ZeilingerK. Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system.Drug Des. Devel. Ther.2019131033104710.2147/DDDT.S18675931037028
     [Google Scholar]
  53. KopsM.S. PesicM. PetersenK.U. SchmalixW.A. StöhrT. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.Eur. J. Pharmacol.202189017363910.1016/j.ejphar.2020.17363933065095
     [Google Scholar]
  54. UptonR.N. MartinezA.M. GrantC. A dose escalation study in sheep of the effects of the benzodiazepine CNS 7056 on sedation, the EEG and the respiratory and cardiovascular systems.Br. J. Pharmacol.20081551526110.1038/bjp.2008.22818552878
     [Google Scholar]
  55. BorkettK.M. RiffD.S. SchwartzH.I. WinkleP.J. PambiancoD.J. LeesJ.P. OgunbiyiW.K. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy.Anesth. Analg.2015120477178010.1213/ANE.000000000000054825502841
     [Google Scholar]
  56. RexD.K. BhandariR. LorchD.G. MeyersM. SchippersF. BernsteinD. Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial.Dig. Liver Dis.20215319410110.1016/j.dld.2020.10.03933243567
     [Google Scholar]
  57. JohnsonK.L. MeyersJ.S. MortensenG.N. SteegeJ.R. MaraK.C. BrinkmanN.J. Remimazolam: A retrospective study of initial safety and recovery data in diverse procedural sedation.Clin. Ther.2024462909510.1016/j.clinthera.2023.11.00438071132
     [Google Scholar]
  58. AyandehA. FarrellN. ShengA.Y. Requirement for discharge in the care of a responsible adult in procedural sedation in the emergency department: Necessity or potential barrier to health equity?J. Emerg. Med.2023654e272e27910.1016/j.jemermed.2023.05.01037679283
     [Google Scholar]
  59. PambiancoD.J. BorkettK.M. RiffD.S. WinkleP.J. SchwartzH.I. MelsonT.I. OgunbiyiW.K. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.Gastrointest. Endosc.201683598499210.1016/j.gie.2015.08.06226363333
     [Google Scholar]
  60. LuoW. SunM. WanJ. ZhangZ. HuangJ. ZhangJ. XiongW. XiaL. XuP. MiaoC. ZhangX. LiuM. ZhongJ. Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: A prospective randomized controlled trial.BMC Anesthesiol.202323118210.1186/s12871‑023‑02092‑237237331
     [Google Scholar]
  61. ChaeD. KimH.C. SongY. ChoiY.S. HanD.W. Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: A randomised, prospective, double-blind study.Br. J. Anaesth.20221291495710.1016/j.bja.2022.02.04035562226
     [Google Scholar]
  62. GaoJ. YangC. JiQ. LiJ. Effect of remimazolam versus propofol for the induction of general anesthesia on cerebral blood flow and oxygen saturation in elderly patients undergoing carotid endarterectomy.BMC Anesthesiol.202323115310.1186/s12871‑023‑02095‑z37142971
     [Google Scholar]
  63. KempenaersS. HansenT.G. Van de VeldeM. Remimazolam and serious adverse events.Eur. J. Anaesthesiol.2023401184185310.1097/EJA.000000000000190237727906
     [Google Scholar]
  64. JeongH. KimH. AhnH.J. An adequate infusion rate of remimazolam for induction of general anesthesia in adult patients: A prospective up-and-down dose-finding study.J. Clin. Med.2023125176310.3390/jcm1205176336902550
     [Google Scholar]
  65. DaiG. PeiL. DuanF. LiaoM. ZhangY. ZhuM. ZhaoZ. ZhangX. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia.Minerva Anestesiol.202187101073107910.23736/S0375‑9393.21.15517‑834263581
     [Google Scholar]
  66. NishiokaY. MiyakeS. HamaokaM. MiyakeK. FujimotoM. HiguchiH. MiyawakiT. Anesthetic management using remimazolam in a hemodialysis patient.Anesth. Prog.2023702656910.2344/anpr‑70‑02‑0637379088
     [Google Scholar]
  67. GoyalP. PuriG.D. PandeyC.K. SrivastvaS. Evaluation of induction doses of propofol: Comparison between endstage renal disease and normal renal function patients.Anaesth. Intensive Care200230558458710.1177/0310057X020300050612413256
     [Google Scholar]
  68. UchidaS. TakekawaD. HashibaE. KudoR. HirotaK. Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: A case report.JA Clin. Rep.2022819910.1186/s40981‑022‑00590‑936572840
     [Google Scholar]
  69. SingalA. NaftalovichR. SyedA.R. ChaudhryF.A. DiscepolaP.J. CorreaR.D.T. Delayed emergence after remimazolam induction in end-stage liver disease.Br. J. Anaesth.20221296e171e17210.1016/j.bja.2022.09.00636208972
     [Google Scholar]
  70. KimotoY. HiranoT. KurataniN. CavanaughD. MasonK.P. Remimazolam as an adjunct to general anesthesia in children: Adverse events and outcomes in a large cohort of 418 cases.J. Clin. Med.20231212393010.3390/jcm1212393037373624
     [Google Scholar]
  71. DongS.A. GuoY. LiuS.S. WuL.L. WuL.N. SongK. WangJ.H. ChenH.R. LiW.Z. LiH.X. ZhangL. YuJ.B. A randomized, controlled clinical trial comparing remimazolam to propofol when combined with alfentanil for sedation during ERCP procedures.J. Clin. Anesth.20238611107710.1016/j.jclinane.2023.11107736764022
     [Google Scholar]
  72. WorthingtonM.T. AntonikL.J. GoldwaterD.R. LeesJ.P. OgunbiyiW.K. BorkettK.M. MitchellM.C. A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy.Anesth. Analg.201311751093110010.1213/ANE.0b013e3182a705ae24108261
     [Google Scholar]
  73. ChangY. HuangY.T. ChiK.Y. HuangY.T. Remimazolam versus propofol for procedural sedation: A meta-analysis of randomized controlled trials.PeerJ202311e1549510.7717/peerj.1549537334113
     [Google Scholar]
  74. PastisN.J. YarmusL.B. SchippersF. OstroffR. ChenA. AkulianJ. WahidiM. ShojaeeS. TannerN.T. CallahanS.P. FeldmanG. LorchD.G.Jr NdukwuI. PritchettM.A. SilvestriG.A. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy.Chest2019155113714610.1016/j.chest.2018.09.01530292760
     [Google Scholar]
  75. ZhouY. ZhaoC. TangY.X. LiuJ.T. Efficacy and safety of remimazolam in bronchoscopic sedation: A meta-analysis.World J. Clin. Cases20241261120112910.12998/wjcc.v12.i6.112038464931
     [Google Scholar]
  76. HiranoT. KimotoY. KurataniN. CavanaughD. MasonK.P. Remimazolam for pediatric procedural sedation: Results of an institutional pilot program.J. Clin. Med.20231218593710.3390/jcm1218593737762878
     [Google Scholar]
  77. TangY. GaoX. XuJ. RenL. QiH. LiR. ShuH. ZouX. YuanS. YangX. ShangY. Remimazolam besylate versus propofol for deep sedation in critically ill patients: A randomized pilot study.Crit. Care202327147410.1186/s13054‑023‑04760‑838049909
     [Google Scholar]
  78. LiX. BuT. LiY.T. XieK.Q. XuZ.Z. LiangX.Q. MuD.L. Sedation efficacy of different dose of remimazolam with sufentanil for nerve block in young and elderly patients: A randomized, controlled study.J. Anesth.202337217718510.1007/s00540‑022‑03142‑836462032
     [Google Scholar]
  79. Food and Drug AdministrationBYFAVO™ (remimazolam) for injection, for intravenous use.Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212295s000lbl.pdf
/content/journals/cn/10.2174/011570159X367968250117034551
Loading
Evaluating Remimazolam for Procedural Sedation
Curr. Neuropharmacol. 23, 1009 (2025); https://doi.org/10.2174/011570159X367968250117034551
/content/journals/cn/10.2174/011570159X367968250117034551
/content/journals/cn/10.2174/011570159X367968250117034551
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): analgesic properties; clinical trials; depressed consciousness; procedural sedation; Remimazolam; remimazolam

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test